Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 499 entries
View as:

Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement

Phase: N/A Priority: Normal
NCT ID: NCT05926427 Org: User:
Start: 08/10/23 End: 04/30/26 Due: 04/30/27

Current Situation of Health Care in Women With HBV or HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT06579313 Org: User:
Start: 09/01/24 End: 07/31/25 Due: 07/31/26

An Early Enteral Nutrition Protocol in Shanghai

Phase: N/A Priority: Normal
NCT ID: NCT03216993 Org: User:
Start: 12/01/18 End: 10/01/21 Due: 10/01/22

Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT04115527 Org: User:
Start: 06/01/18 End: 12/31/23 Due: 12/31/24

Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT04211051 Org: User:
Start: 04/15/20 End: 10/21/20 Due: 10/21/21

A Longitudinal Study of Choroidal Changes After Cataract Surgery in Eyes With Diabetic Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT04499768 Org: User:
Start: 06/01/18 End: 12/30/20 Due: 12/30/21

Remote Programming for Deep Brain Stimulation in Parkinson's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06078397 Org: User:
Start: 10/30/23 End: 06/30/25 Due: 06/30/26

a Ultrasonographic Measurement of Intra-abdominal Pressure

Phase: N/A Priority: Normal
NCT ID: NCT06390605 Org: User:
Start: 05/01/24 End: 05/01/25 Due: 05/01/26

Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in Shanghai

Phase: N/A Priority: Normal
NCT ID: NCT05375786 Org: User:
Start: 04/02/22 End: 07/31/22 Due: 07/31/23

A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center

Phase: N/A Priority: Normal
NCT ID: NCT06949241 Org: User:
Start: 12/01/19 End: 02/02/26 Due: 02/02/27

A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06949267 Org: User:
Start: 06/01/25 End: 03/31/28 Due: 03/31/29

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01356472 Org: User:
Start: 06/30/11 End: - Due: -

A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies

Phase: N/A Priority: Normal
NCT ID: NCT04534023 Org: User:
Start: 09/01/20 End: 09/30/26 Due: 09/30/27

Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT01998334 Org: User:
Start: 07/31/12 End: 12/31/16 Due: 12/31/17

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03413930 Org: User:
Start: 06/30/19 End: 03/31/26 Due: 03/31/27

Quantitative Ultrasound Assessment of Abdominal Cavity Space

Phase: N/A Priority: Normal
NCT ID: NCT06634732 Org: User:
Start: 11/01/24 End: 12/31/25 Due: 12/31/26

PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)

Phase: N/A Priority: Normal
NCT ID: NCT06074692 Org: User:
Start: 06/01/23 End: 12/30/26 Due: 12/30/27

An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

Phase: N/A Priority: Normal
NCT ID: NCT06339060 Org: User:
Start: 05/01/24 End: 03/01/28 Due: 03/01/29

Cognitive Impairment Cohort Study of the Elderly Population in YuGarden

Phase: N/A Priority: Normal
NCT ID: NCT06325527 Org: User:
Start: 04/01/24 End: 06/01/31 Due: 06/01/32

Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03882866 Org: User:
Start: 03/28/19 End: 09/30/21 Due: 09/30/22

A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04434833 Org: User:
Start: 07/01/20 End: 06/30/23 Due: 06/30/24

RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04253847 Org: User:
Start: 02/15/20 End: 02/28/27 Due: 02/28/28

A Real-World Study on Extranodal Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06573099 Org: User:
Start: 09/01/24 End: 09/01/29 Due: 09/01/30

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

Phase: N/A Priority: Normal
NCT ID: NCT04858724 Org: User:
Start: 12/01/20 End: 06/30/24 Due: 06/30/25

Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT

Phase: N/A Priority: Normal
NCT ID: NCT05896007 Org: User:
Start: 07/13/23 End: 12/31/25 Due: 12/31/26